|
|
|
|
LEADER |
01144nam a2200241 u 4500 |
001 |
EB002001301 |
003 |
EBX01000000000000001164202 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
210907 r ||| eng |
245 |
0 |
0 |
|a CADTH report
|h Elektronische Ressource
|b project in briefs
|
260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c 2011, 2011-
|
300 |
|
|
|a 1 online resource
|
653 |
|
|
|a Canada
|
653 |
|
|
|a Technology Assessment, Biomedical
|
653 |
|
|
|a Evidence-Based Medicine
|
710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK355757
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 600
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a The Canadian Agency for Drugs and Technologies in Health (CADTH) is an independent, not-for-profit producer and broker of health technology assessments. Health care decision-makers rely on our work to make evidence-informed policy and practice decisions about drugs and other health technologies
|